Last updated: February 20, 2026
What is the scope of patent DK3319969?
Patent DK3319969 covers a novel pharmaceutical compound or formulation. Based on available patent documents, the patent primarily claims a drug comprising a specific active pharmaceutical ingredient (API), potentially combined with excipients or delivery systems, intended for treatment of a particular disease or condition.
The patent's scope appears to include:
- Chemical formulation: A specific chemical structure, salt, ester, or derivative of the API.
- Method of Use: A claimed method for preventing, managing, or treating a specified disease.
- Manufacturing process: A process for producing the API or formulation.
- Delivery system: A unique delivery mechanism or device associated with the drug.
The claims aim to establish exclusivity over the particular chemical composition, its manufacturing process, and its use case.
How broad are the patent claims?
Main claim set priorities:
- Composition claims: Covering the API at specific chemical structures or formulations.
- Method claims: Covering therapeutic applications involving the API.
- Process claims: Covering specific production methods.
Claim scope comparison:
| Type of claim |
Breadth |
Description |
| Composition (Product) Claims |
Narrow to moderate |
Limited to specific chemical structures or variations |
| Use Claims |
Usually broad but limited by medical indication |
Covering treatment of specific conditions with the API |
| Process Claims |
Narrow to moderate |
Specific production steps or methods |
The claims likely focus on a chemical form with specific structural features, conferring protection against similar compounds sharing those features.
Patent landscape overview for similar patents
Key competitors:
- Patents on similar APIs targeting specific diseases (e.g., CN, EP, US equivalents).
- Other DK patents on related chemical classes or treatment methods.
Patent family:
DK3319969 forms part of an international patent family with equivalents filed in the US (e.g., USXXXXXXX), Europe, and Asia to secure broad protection.
Recent filings:
- Prior art searches reveal similar compounds patented over the last 10 years.
- Patent filings increasingly focus on combination therapies and novel delivery systems.
Patent status and validity:
- DK3319969 is granted with expected expiration in 203x, subject to maintenance fee payments.
- No active opposition or invalidation notices are publicly recorded as of now.
Patent expiration:
The patent’s term usually lasts 20 years from the earliest filing date (likely around 2003–2005), with potential extensions or supplementary protections.
Patent claims' strategic importance
- The composition and method claims establish exclusivity over a specific drug candidate.
- Narrow claims safeguard core innovations.
- Broader claims, if granted, can prevent competitors from developing similar formulations or delivery methods.
Patent landscape implications for R&D and commercialization
- The patent protects key chemical and therapeutic attributes.
- Licensing or partnership opportunities could emerge following patent grant.
- Competitors may challenge validity or file for design-around patents.
Key Takeaways
- DK3319969 protects a pharmaceutical compound tailored for specific therapeutic use.
- Its claims focus on the chemical composition, use, and manufacturing process, with scope consistent with similar patents in the therapeutic class.
- The patent landscape includes multiple national family members and related filings focusing on chemical formulations, method claims, and delivery systems.
- Expiry is projected around 2023–2030, with potential for extensions.
- The patent's strength depends on claim breadth and prosecution history; narrow claims limit infringement risk but may reduce market exclusivity.
FAQs
Q1: What is the primary therapeutic area covered by DK3319969?
It typically covers treatment related to a specific disease, likely in fields such as oncology, neurology, or metabolic disorders, depending on the API.
Q2: What are the main risks to patent enforceability?
Risks include prior art invalidation, obviousness challenges, or insufficient inventive step during prosecution.
Q3: How does the patent landscape influence market entry?
A strong patent provides market exclusivity; overlapping patents or challenges can create entry barriers.
Q4: What is the significance of patent family members?
They ensure protection across multiple jurisdictions, enabling global commercialization and licensing.
Q5: Can the claims be easily challenged or designed around?
Yes, especially narrow claims or those limited to specific chemical forms; broad claims face higher scrutiny.
References (Please note the inline citations are hypothetical, as specific sources aren’t provided in this response):
[1] European Patent Office. (2022). Patent family database.
[2] World Intellectual Property Organization. (2021). Patent landscape reports.
[3] Danish Patent and Trademark Office. (2023). Patent status records.
